(Sharecast News) - Niox Group said on Thursday that trading so far in 2026 had been in line with management expectations, as the medical device company reported an improved cash position and signed a long-term supply agreement for its FeNO sensors.
The AIM-traded asthma and COPD diagnostics specialist said cash stood...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE